TO Nielsen

1.0k total citations
9 papers, 25 citations indexed

About

TO Nielsen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, TO Nielsen has authored 9 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in TO Nielsen's work include Breast Cancer Treatment Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Advanced Breast Cancer Therapies (2 papers). TO Nielsen is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Advanced Breast Cancer Therapies (2 papers). TO Nielsen collaborates with scholars based in Canada, United States and United Kingdom. TO Nielsen's co-authors include Matthew J. Ellis, Ann D. Thor, Samuel Leung, Anne‐Vibeke Lænkholm, Dorte Nielsen, Dongxia Gao, Donald A. Berry, Maj‐Britt Jensen, S. Edgerton and Scott D. Jewell and has published in prestigious journals such as Cancer Research, Breast Cancer Research and Treatment and OncoImmunology.

In The Last Decade

TO Nielsen

9 papers receiving 24 citations

Peers

Countries citing papers authored by TO Nielsen

Since Specialization

Citations

This map shows the geographic impact of TO Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TO Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TO Nielsen more than expected).

Fields of papers citing papers by TO Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TO Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TO Nielsen. The network helps show where TO Nielsen may publish in the future.

Co-authorship network of co-authors of TO Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of TO Nielsen. A scholar is included among the top collaborators of TO Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TO Nielsen. TO Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine 2021 ·OncoImmunology ·Elisabeth Specht Stovgaard, Karama Asleh, Nazia Riaz, Samuel Leung, Dongxia Gao, (unknown), Anne‐Vibeke Lænkholm, Eva Balslev, Maj‐Britt Jensen, Dorte Nielsen, TO Nielsen	9
2	Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trial 2019 ·Cancer Research ·Saranya Chumsri, Karama Asleh, (unknown), Afshin Mashadi-Hossein, (unknown), Henrik Lindman, TO Nielsen, Heikki Joensuu, E. Aubrey Thompson	1
3	S845 PREDICTED NEOANTIGENS PROVIDE PROGNOSTIC INSIGHT IN DLBCL 2019 ·HemaSphere ·Joseph N. Paulson, Dayong Jin, Ethan Sokol, TO Nielsen, (unknown), (unknown)	1
4	Abstract P3-05-12: VISTA expression on tumor-infiltrating lymphocytes in breast cancer: Clinical correlates and association with PD-1 2018 ·Cancer Research ·(unknown), Dongxia Gao, TO Nielsen	1
5	Abstract S2-07: An international Ki67 reproducibility study: Harmonizing scoring methodology 2013 ·Cancer Research ·TO Nielsen, (unknown)	1
6	Abstract S4-6: An international Ki67 reproducibility study 2012 ·Cancer Research ·TO Nielsen, (unknown), (unknown), Mauro G. Mastropasqua, (unknown), JMS Bartlett, Giuseppe Viale, (unknown), (unknown), Mitch Dowsett	3
7	Abstract P3-06-03: Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients 2012 ·Cancer Research ·(unknown), TO Nielsen, (unknown), (unknown), Brett Wallden, Eva Balslev, (unknown), Bent Ejlertsen	2
8	Benefits of Adding Paclitaxel to Adjuvant Doxorubicin/Cyclophosphamide Depending on HER2 & ER Status: Analysis of Tumor Tissue Microarrays and Immunohistochemistry in CALGB 9344 (Intergroup 0148). 2009 ·Cancer Research ·Donald A. Berry, Ann D. Thor, Scott D. Jewell, Gloria Broadwater, S. Edgerton, Daniel M. Hayes, Clifford A. Hudis, (unknown), TO Nielsen, Matthew J. Ellis	6
9	2. Survival Impact of HER-2/Neu, Cox-2, Urokinase Plasminogen Activator (upa), Cytokeratin 17/5,6 and other Markers with Long-Term Outcome of Early Breast Cancer. Report from the British Columbia Tissue Micro-Array Project (BCTMAP) 2003 ·Breast Cancer Research and Treatment ·Joseph Ragaz, Marc E. Lippman, Matt van de Rijn, Angela Brodie, Danijela Jelovac, TO Nielsen, Shoukat Dedhar, David G. Huntsman, Malcolm Hayes, Sandra E. Dunn, Mei‐chun Cheung, G. W. Sledge, Stephen Chia, Adrian L. Harris, Chris Bajdik, Caroline Speers, John J. Spinelli, Daniel F. Hayes	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact